Author: Citron, M.
Description: Alzheimer’s disease is the single biggest unmet medical need in neurology. Current drugs are safe, but of limited benefit to most patients. This review discusses the scientific basis and current status of promising disease-modifying therapies in the discovery and development stages. I describe the major targets of anti-amyloid therapy and the main focus of disease modification approaches. In addition, two new potential treatment approaches supported by retrospective epidemiology are outlined.
Subject headings: Alzheimer Disease/metabolism/physiopathology/therapy; Amyloid beta-Peptides/antagonists & inhibitors/biosynthesis; Animals; Brain/drug effects/metabolism/physiopathology; Disease Models, Animal; Drug Design; Drug Evaluation/trends; Drug Industry/trends; Enzyme Inhibitors/pharmacology/therapeutic use; Humans
Publication year: 2002
Journal or book title: Nature Neuroscience
Find the full text : https://www.nature.com/articles/nn940
Find more like this one (cited by): https://scholar.google.com/scholar?cites=6923925419861977464&as_sdt=1000005&sciodt=0,16&hl=en
Type: Journal Article
Serial number: 137